Join us to explore the clinical aspects of heart failure and the clinical utility of Natriuretic Peptide assays
within Asia Pacific.
within Asia Pacific.
- Pathophysiology of Heart Failure and its position in the Continuum of Cardiovascular Disease
- Diagnosis and Classification of Heart Failure: Introduction to the Universal Definition of Heart Failure Consensus Statement published in April 2021
- Brief overview of the clinical management of Heart Failure
- The importance of Natriuretic Peptides (BNP and NT-proBNP) in the diagnosis, prognosis and
management of Heart Failure - Clinical utility of Natriuretic Peptide assays in Asia Pacific – best practice sharing from AP region
Date : 6 May 2021 | Thursday Time : 2.30 pm – 3.30 pm Malaysia time Location : Microsoft Teams |
![]()
|
[button link=”https://www.siemens-healthineers.com/en-my/news-and-events/events-malaysia/macb-heart-failure?stc=myhc100075″ color=”pink” newwindow=”yes”] Click here to register[/button]
Register by 4 May 2021!
Kindly contact Lai Cheng at lai-cheng.leong@siemens-healthineers.com for more details.
Supported by